Sotera Health (NASDAQ:SHC) Releases Earnings Results, Beats Estimates By $0.02 EPS

Sotera Health (NASDAQ:SHC) posted its quarterly earnings data on Tuesday. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.02, FiscalAI reports. Sotera Health had a return on equity of 43.69% and a net margin of 4.82%.The company had revenue of $303.44 million during the quarter, compared to analysts’ expectations of $300.68 million. During the same period in the prior year, the business earned $0.21 earnings per share. Sotera Health’s revenue for the quarter was up 4.6% compared to the same quarter last year. Sotera Health updated its FY 2026 guidance to 0.930-1.01 EPS.

Sotera Health Stock Performance

Shares of NASDAQ:SHC opened at $17.49 on Tuesday. The company has a debt-to-equity ratio of 4.04, a current ratio of 2.38 and a quick ratio of 2.18. The business’s fifty day moving average price is $17.99 and its two-hundred day moving average price is $16.81. Sotera Health has a fifty-two week low of $9.53 and a fifty-two week high of $19.85. The stock has a market capitalization of $4.97 billion, a price-to-earnings ratio of 92.06 and a beta of 1.82.

Insider Activity

In related news, Director Gtcr Investment Xi Llc sold 6,480,000 shares of the stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $16.33, for a total transaction of $105,818,400.00. Following the completion of the sale, the director owned 22,735,301 shares in the company, valued at $371,267,465.33. This trade represents a 22.18% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Michael B. Jr. Petras sold 434,104 shares of the business’s stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $16.45, for a total transaction of $7,141,010.80. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 17,384,104 shares of company stock worth $284,024,511. Corporate insiders own 55.12% of the company’s stock.

Institutional Trading of Sotera Health

Several hedge funds have recently modified their holdings of the company. EverSource Wealth Advisors LLC boosted its holdings in shares of Sotera Health by 831.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after acquiring an additional 2,935 shares in the last quarter. Wells Fargo & Company MN raised its position in Sotera Health by 736.5% in the 4th quarter. Wells Fargo & Company MN now owns 4,283 shares of the company’s stock valued at $76,000 after purchasing an additional 3,771 shares during the last quarter. Quadrant Capital Group LLC acquired a new position in Sotera Health in the third quarter worth $86,000. Los Angeles Capital Management LLC bought a new stake in shares of Sotera Health during the fourth quarter worth $90,000. Finally, PNC Financial Services Group Inc. increased its stake in shares of Sotera Health by 10.8% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,204 shares of the company’s stock valued at $127,000 after buying an additional 705 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on SHC. Piper Sandler raised shares of Sotera Health from a “neutral” rating to an “overweight” rating and increased their price target for the company from $17.00 to $24.00 in a report on Friday, January 9th. JPMorgan Chase & Co. raised their price objective on Sotera Health from $14.00 to $16.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 5th. Royal Bank Of Canada started coverage on Sotera Health in a report on Thursday, January 8th. They set an “outperform” rating and a $24.00 price objective on the stock. Wells Fargo & Company lowered Sotera Health to an “overweight” rating in a research note on Thursday, January 8th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Sotera Health in a research note on Monday, December 29th. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $20.00.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.